These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1841 related items for PubMed ID: 2524501
1. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ. J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [Abstract] [Full Text] [Related]
2. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. Steingold K, De Ziegler D, Cedars M, Meldrum DR, Lu JK, Judd HL, Chang RJ. J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031 [Abstract] [Full Text] [Related]
3. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R. J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389 [Abstract] [Full Text] [Related]
10. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions. Heikinheimo O, Gordon K, Williams RF, Hodgen GD. Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191 [Abstract] [Full Text] [Related]
16. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns. Kuhl H, Jung C, Taubert HD. Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376 [Abstract] [Full Text] [Related]
17. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome. White D, Leigh A, Wilson C, Donaldson A, Franks S. Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565 [Abstract] [Full Text] [Related]
18. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL, Monroe SE, Marshall LA, Fluker MR, Nerenberg CA, Jaffe RB. J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [Abstract] [Full Text] [Related]
19. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome. Gonzalez F, Hatala DA, Speroff L. Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519 [Abstract] [Full Text] [Related]
20. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome. Berga SL, Yen SS. Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984 [Abstract] [Full Text] [Related] Page: [Next] [New Search]